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Abstract 
Background: Deregulation of glycemic and glycated hemoglobin (HbA1) levels accelerate the progression of car-
diovascular complications in type 1 diabetes mellitus (T1DM). The aim of this study was to investigate the association 
between HbA1 and changes in blood pressure of children and adolescents with T1DM.
Methods: A total of 60 children and adolescents were recruited and allocated into two groups (prehypertension and 
control group). Blood pressure and HbA1 were measured by the oscillometric method and high-performance liquid 
chromatography, respectively.
Results: The prehypertensive group had (P < 0.05) higher disease duration, body weight, Z score for body weight, 
systolic blood pressure (SBP), diastolic blood pressure (DBP) and a higher HbA1 when compared with the control chil-
dren and adolescents. Multiple regression to predict alterations in DBP from HbA1 adjusted for age, disease duration, 
and body mass index demonstrated a positive relationship with DBP (P < 0.05). A 1 % increase in HbA1 was associated 
with 1.73 mmHg increase in DBP.
Conclusions: High levels of HbA1 may be associated with increased blood pressure in T1DM. A tight control of HbA1 
levels may provide long-term cardiovascular protection in children and adolescents with T1DM.
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Background
Type 1 diabetes mellitus (T1DM) is associated with 
several chronic complications, such as hypertension, 
nephropathy and dyslipidemia. Furthermore, children 
with T1DM and hypertension present higher pulse pres-
sure and ambulatory stiffness index levels when com-
pared with normotensive patients [1]. Elevated values of 
blood pressure (BP) in children with T1DM are associ-
ated with an increased risk for developing cardiovascu-
lar complications later in life [1]. Consequently, the early 
assessment of hypertension, diagnosis, management and 
treatment is critical in reducing long term microvascular 
and macrovascular complications [2]. Currently, chil-
dren and adolescents with BP levels of 120/80  mmHg 
or above, but less than 95th percentile, are classified as 
prehypertensive [3]. Thus, the control of risk factors that 
might be independently associated with hypertension 
may improve the care and management of children and 
adolescents with T1DM [4].
Pietrzak et  al. [5], investigated the impact of body 
mass index (BMI) on BP in 164 patients with T1DM 
aged 14 years. Results revealed a positive correlation of 
systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) with age and BMI, while diabetes duration 
was only correlated with DBP. Although glycated hemo-
globin (HbA1) was correlated with BMI, this parameter 
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in T1DM adolescents, which could be a more sensible 
indicator as compared with BMI. Interestingly, Rohani 
et al. [6], evaluated 62 T1DM patients with HbA1 < 7 % 
and observed that 26  % were in the pre-hypertensive 
stage. Moreover, elevated BP was correlated with the 
duration of the disease, but not with HbA1. Thus, it 
seems reasonable to investigate the association of differ-
ent HbA1 ranges with BP values in T1DM in children 
and adolescents.
In a prospective analysis of 9603 middle-aged partici-
pants with and without a previous history of diabetes, 
Bower et al. [7] estimated the association between HbA1 
and hypertension prevalence. Interestingly, subjects with 
elevated HbA1 had higher mean fasting glucose, BP, BMI, 
low density lipoprotein (LDL), cholesterol and triglyc-
eride levels. Furthermore, higher baseline HbA1 values 
were associated with increased risk of hypertension dur-
ing long-term follow-up [7].
Considering that HbA1 < 7.5 % is recommended for all 
pediatric age-groups [4], the lack of correlation between 
BP and HbA1 in the studies from Rohani et  al. [6] and 
Pietrzak et  al. [5], may be explained by the well-con-
trolled HbA1 of the patients. Thus, a poor HbA1 control 
in T1DM children and adolescents might influence BP.
In this sense, the aim of the present study was to inves-
tigate the association between HbA1 and changes in BP 
in T1DM children and adolescents. The initial hypothesis 
is that the higher HbA1 levels the higher BP values.
Methods
Study population
A total of 60 children and adolescents with an estab-
lished diagnosis of T1DM [2] (age: 12 ± 1 years, height: 
1.57 ± 0.07 m, weight: 48.58 ± 8.76 kg, body mass index: 
19.63  ±  2.96  kg/m2, 29 males and 31 females) were 
recruited from Taguatinga Regional Hospital (Brazil, Bra-
silia, DF) and participated in the study between February 
of 2014 and July of 2015.
Participants were classified as prehypertensive (n = 22) 
or normotensive (n = 38) according to the Fourth Report 
on the Diagnosis, Evaluation, and Treatment of High 
Blood pressure in Children and Adolescents [3]. It is now 
recommended that, as with adults, children and ado-
lescents with blood pressure levels at 120/80  mmHg or 
above should be considered prehypertensive.
Anthropometric and body composition evaluation
Height was measured using a stadiometer and weight in 
a scale, and were used for the calculation of the BMI (kg/
m2). The Z score for weight, height and BMI were used 
for analysis and were calculated by growth charts (Cent-
ers for Disease Control and Prevention, National Center 
for Health Statistics, 2000) recommended for clinical and 
research purposes in children and adolescents. Further-
more, overweight and normal weight groups were sepa-
rated according to the Z score for BMI according to the 
World Health Organization (WHO) [8].
Hemodynamic measurements
Systolic blood pressure, diastolic blood pressure and 
heart rate (HR) were measured with an oscillometric 
device (Microlife 3AC1-1, Widnau, Switzerland) accord-
ing to the recommendations of the Fourth Report on 
the Diagnosis, Evaluation, and Treatment of High Blood 
pressure in Children and Adolescents [3]. The cuff size 
was adapted to the circumference of the arm of each par-
ticipant according to the manufacture’s recommenda-
tions. All office BP measures were assessed in triplicate 
(measurements separated by 1  min) in a calm environ-
ment and with an adequate cuff size, with the mean value 
used for analysis. During BP measurements participants 
remained seated quietly in a controlled room tempera-
ture environment.
Blood analysis
Participants reported to the laboratory between 08:00 and 
10:00 a.m., after an overnight fast, and after blood col-
lection, samples were centrifuged at room temperature 
at 2000 rpm for 15 min. All subjects were encouraged to 
avoid smoking, alcohol and caffeine consumption as well 
as unusual physical activity to avoid influence on these 
parameters. All patients provided blood samples and the 
concentration of glucose (mg/dL), HbA1 (%), high density 
lipoprotein (HDL), LDL, triglycerides and total choles-
terol were measured. Glucose and HbA1 were measured 
by high-performance liquid chromatography (Bio-Rad, 
Brazil). The lipid profile was measured by an enzymatic 
colorimetric method on autohumalyzer equipment 
(Human GMBH, Germany). High density lipoprotein was 
determined by ionic exchange followed by colorimetric 
reaction with the Linco Research Inc. kit (St Louis, USA).
Statistical analysis
The results are expressed as mean and standard devia-
tion (SD). The Shapiro–Wilk test was used to analyze 
the normality of the data. For comparisons between 
groups, an independent-t test was applied and for non-
parametric data the Mann–Whitney test was used. A 
bivariate correlation using Pearson’s test was used to 
assess the correlation between age, disease duration, 
HbA1 and BMI with BP as the main outcome [9]. The 
strength and magnitude of the correlation between vari-
ables was classified as follows [10]: ±1.0 perfect, ±0.7 
to ±0.9 strong, ±0.4 to ±0.6 moderate, ±0.1 to  ±0.3 
weak and 0 zero. After that, a multiple regression 
analysis was performed and BP was analyzed as the 
Page 3 of 6de Oliveira et al. Diabetol Metab Syndr  (2016) 8:4 
dependent variable and adjusted for several confound-
ing variables, such as age, disease duration, and BMI 
[5]. Significance was accepted at the P ≤ 0.05 and analy-
ses were conducted with SPSS version 18.0 (SPSS Inc., 
Chicago).
The study was approved by the Fundação de Ensino 
e Pesquisa em Ciências da Saúde (nº 710.782) and 
approved by the Institutional Research Ethics Comitte of 
Catholic University of Brasilia (nº 681.469) in accordance 
with the declaration of Helsinki. Informed consent was 
obtained from parents and informed assent from chil-
dren and adolescents.
Results
Descriptive characteristics of the study participants 
are shown in Table  1. The prehypertensive group dem-
onstrated significantly higher T1DM disease dura-
tion, body weight, Z score body weight, SBP, DBP and 
HbA1 as compared with the normotensive group of 
children and adolescents with T1DM, although no dif-
ferences were verified for BMI z-score (Table  1). The 
analysis according to gender revealed that female indi-
viduals displayed a higher basal HR when compared 
with the male individuals, with no differences for 
anthropometric and biochemical variables (Table  1). In 
addition, children’s were divided into overweight and 
normal body weight. There was no significant differ-
ence (P  =  0.619) in SBP when groups were separated 
for overweight (114.3  ±1.3  mmHg) and normal body 
weight (112.4 ± 1.16 mmHg). However, there was a ten-
dency toward statistical significance (P = 0.052) for DBP 
between overweight (75.5 ± 3.33 mmHg) and the normal 
body weight (68.6 ± 1.4) group (Fig. 1). 
Although not statistically significant, there was a posi-
tive weak correlation between age, diagnosis time, HbA1 
and BMI with blood pressure. In addition, DBP and HbA1 
demonstrated a positive, significant, and moderate corre-
lation (values of ± 0.5; Table 2).
Following the correlational analysis, a multiple regres-
sion was run to predict alterations on DBP from HbA1 
adjusted for age, diagnosis time, and BMI (categorical 
variable used to allocate children and adolescents into 
eutrophic and overweight according to BMI cutoffs for 
teenagers and children [8]). The model significantly pre-
dicted DBP (CI 95  % for Beta between 0.68 and 2.78, 
P =  0.003), and HbA1 demonstrated a positive correla-
tion with DBP. According to this model, each 1 % increase 
in HbA1 is associated with an increase of 1.73  mmHg 
in DBP (Table  3). For SBP the regression, the adjusted 
model for the same covariates used in DBP was assessed, 
and the model did not improve the ability to predict the 
outcome variable (P = 0.11).
Table 1 Differences between groups and gender demonstrated by means and standard deviation (SD)
SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, HbA1 glycated hemoglobin
* P ≤ 0.05
a Data not normally distributed is presented as median, minimum and maximum values
b  Comparisons between sexes
Normotensive Prehypertension P Pb Boys Girls
Disease duration, years 5.32 ± 3.62 7.54 ± 3.78* 0.029 0.758 6.31 ± 4.26 6.00 ± 3.38
Age, years 12.78 ± 1.16 13.27 ± 1.20 0.132 0.132 13.20 ± 1.36 12.74 ± 0.99
Body weight, kg 46.40 ± 9.04 52.38 ± 6.90* 0.013 0.852 48.35 ± 8.09 48.80 ± 9.50
Height, cm 1.56 ± 0.06 1.59 ± 0.07 0.082 0.077 1.59 ± 0.07 1.55 ± 0.06
Body mass index, kg/m2 19.09 ± 3.10 20.58 ± 2.48 0.080 0.172 19.07 ± 2.30 20.20 ± 3.45
Z score body weighta −0.57 (−4.72 to 1.62) 0.05 (−1.63 to 1.33)* 0.042 0.731 −0.11 (−4.72 to 1.62) −0.50 (−2.15 to 
1.34)
Z score heighta −0.73 (−1.89 to 1.68) −0.21 (−2.21 to 1.18) 0.154 0.747 −0.68 (−1.75 to 1.18) −0.40 (−2.21 to 
1.68)
Z score body mass indexa −0.03 (−4.72 to 1.58) 0.23 (−0.95 to 1.17) 0.213 0.642 0.04 (−1.69 to 1.41) 0.15 (−4.72 to 1.58)
SBP, mmHg 107.86 ± 7.32 122.59 ± 6.88* 0.001 0.498 112.34 ± 11.83 114.12 ± 8.22
DBP, mmHg 66.39 ± 5.49 77.04 ± 10.59* 0.001 0.272 68.93 ± 9.83 71.58 ± 8.64
HR, bpm 86.83 ± 15.001 92.27 ± 18.12 0.221 0.024* 83.92 ± 15.22 95.53 ± 16.17
Glycaemia, mg/dl 215.47 ± 90.91 204.00 ± 113.03 0.752 0.978 212.15 ± 82.62 211.21 ± 117.94
HbA1,  % 9.74 ± 1.98 11.58 ± 3.08* 0.037 0.573 10.17 ± 2.46 10.60 ± 2.67
HDL, mg/dl 54.47 ± 8.45 51.14 ± 12.22 0.333 0.782 52.80 ± 8.48 53.75 ± 12.00
LDL, mg/dl 102.22 ± 25.78 102.50 ± 38.72 0.979 0.814 103.39 ± 30.86 100.93 ± 31.63
Triglycerides, mg/dl 89.44 ± 40.29 92.53 ± 44.39 0.820 0.138 81.91 ± 38.10 101.00 ± 43.57
Total cholesterol, mg/dl 169.78 ± 39.06 177.00 ± 38.67 0.566 0.750 170.52 ± 44.92 174.35 ± 30.87
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Discussion
There are relatively few studies investigating the impact 
of HbA1 on BP in children and adolescents with T1DM. 
A multiple regression analysis with adjustment for age, 
T1DM disease duration and BMI revealed a positive cor-
relation between DBP and HbA1. In addition, this study 
demonstrated that prehypertensive children and adoles-
cents with T1DM presented increased time of disease 
duration, as well as higher SBP, DBP and HbA1 values.
Moreover, comparisons between gender were made 
in this study, because it is an important predictor of 
the alteration in carotid artery intima-media-thickness 
and there is a relationship between CCA and IMT and 
established cardiovascular disease risk factors, such as 
hypertension and the quality of the metabolic glycemic 
control (estimated by HbA1) in children and adoles-
cents with T1DM [11]. In addition, in a previous study, 
boys with T1DM presented higher fasting glucose, 
lower intima-media-thickness and a lower body mass 
index (kg/m2) when compared with girls with T1DM 
[11].
The results of this study revealed that HbA1 presented 
a positive correlation with DBP, even adjusted for sev-
eral confounding variables, such as age, disease duration, 
and BMI, while no correlation was found with SBP. These 
results are relevant because, each 1 % increase in HbA1 is 
associated with an increase of 1.73  mmHg in DBP. This 
increment, although small, can augment the risk of stroke 
by 14-17 %, and risk of coronary artery disease by 6-9 %, in 
the general population [12].
The benefits of better BP and lipid levels control were 
clearly demonstrated by an observational prospec-
tive study of 589 patients with childhood-onset T1DM 
(<17  years) [13]. Higher values for SBP, DBP and lipid 
levels were associated with higher relative risks for mor-
tality, coronary artery disease and nephropathy. Further-
more, even a small reduction of 2  mmHg in DBP, for 
example, can have a great impact in terms of number of 
cardiovascular events prevented, such as coronary heart 
disease and stroke [14].
Nevertheless, hyperglycemia (evaluated by HbA1) 
that is intimately related with glycemic control, plays 
Fig. 1 Systolic blood pressure (SBP) and diastolic blood pressure (DBP) between overweight and normal body weight children and adolescents 
with T1DM. Data presented as means and standard deviation (SD)
Table 2 Correlation between blood pressure and age, disease duration, HbA1 and body mass index
HbA1 glycated hemoglobin
* P ≤ 0.05
Parameter Systolic blood pressure P Diastolic blood pressure P
Disease duration, years R = 0.13 0.297 R = 0.00 0.960
Age, years R = 0.12 0.326 R = 0.20 0.113
Body mass index, kg/m2 R = 0.24 0.081 R = 0.21 0.113
HbA1,  % R = 0.24 0.089 R = 0.54* 0.001
Table 3 Correlation between  HbA1 and  diastolic blood 
pressure adjusted for  age, disease duration, and  body 
mass index
a Adjusted for age, disease duration and body mass index
HbA1 glycated hemoglobin
* P ≤ 0.05
Variable B SEB β P
Intercept 29.11 14.80 0.058
HbA1,  %
a 1.73 0.51 0.48 0.002*
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an important role in the development of microvascular 
complications [15] [13]. The levels of HbA1 in children 
and adolescents with T1DM of the present study were 
higher than the <7.5  % recommended across all pedi-
atric age-groups. Moreover, there is an association of 
high HbA1 levels with hyperglycemia, dyslipidemia and 
hyperinsulinemia, which mediates vascular dysfunc-
tion, activation of the renin-angiotensin-aldosterone sys-
tem, sympathetic nervous system, and possibly negative 
alterations in BP [16]. It appears that a lack of association 
between HbA1 and BP in previous studies [5, 6] might be 
explained by the well-controlled HbA1 levels of children 
and adolescents with T1DM.
Moreover, when comparing children and adoles-
cents with T1DM to obese children and adolescents 
without T1DM, BP depends on BMI [5, 17, 18]. When 
groups were separated according to Z score for BMI 
[8] [8], mean BP values in the groups of patients classi-
fied as overweight were higher, but not statistically sig-
nificant different when compared with the normal body 
weight group (SBP  =  114.25  ±  3.84 vs. 112.44  ±  9.96; 
DBP = 75.50 ± 9.42 vs. 68.60 ± 8.76 for overweight and 
normal body mass, respectively).
In addition, prehypertensive children and adolescents 
with T1DM displayed a longer disease duration and 
higher BP. Nonetheless, Wigmann et al. [19], found that 
the elevation of BP, albuminuria, and renal dysfunction 
were altered in parallel when comparing groups with 
increased disease duration in 166 T1DM patients aged 
25  years. These results suggest that disease duration of 
T1DM is an interesting topic of research to pursue in fur-
ther investigations.
The values of glycemic control in this study are simi-
lar to the study from Ngwiri et  al. [20], where children 
and adolescents with T1DM from Sub-Saharam Africa 
presented a median HbA1 of 11 %. An interesting result 
was that age above 12 years was significantly associated 
with poor glycemic control. The poor glycemic control 
reported in this study is far from being acceptable and 
most of the participants of this study might present a 
high risk for the precocious development of microvascu-
lar complications. Therefore, this data strongly reinforce 
the importance of counseling children and adolescents 
with T1DM regarding management, follow-up, and more 
resources should be provided on care of this disease. We 
agree that the education and follow-up of children and 
adolescents with T1DM must be analyzed according to 
economic status, educational level, social level, and avail-
able resources. Another important topic to be considered 
is the viability of educational methods for profession-
als and the institutions involved. The programs must be 
coherent as the feasibility, scope, access, cost-effective 
and proposed goals, and should be adapted according to 
the health system [21].
It should be noted that this study presents some 
limitations. Diabetes education differs from country 
to country, and the control of educational strategies 
by parents and their children regarding HbA1 values 
that help to prevent long term micro- and macrovas-
cular complications were not controlled in this study. 
We are aware that education variables in the location 
where the present study was conducted could be more 
personalized. However, proper diabetes education for 
children and adolescents with T1DM, and their family 
is a complex condition, which requires educators with 
a set of skills including good communication, com-
passion, sensitivity, humor, and in-depth knowledge 
of childhood diabetes [2]. Furthermore, the lack of 
controlled maturational status [22, 23], daily dose of 
insulin prescribed, renal status, and physical activity 
[24, 25] might be important confounding factors that 
should be analyzed in future studies.
Conclusions
A poor glycemic control might represent an impor-
tant factor to be controlled by educational programs as 
a strategy to prevent hypertension and associated long-
term cardiovascular problems in children and adoles-
cents with T1DM. Health behaviors, such as appropriate 
nutrition and exercise should be recommended as an 
adjunct to the prescribed medication therapy.
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